Acc
Two abstracts on AI-derived retinal biomarkers for cardiovascular risk accepted to ACC 2026 in New Orleans (OCTA biomarkers for coronary microvascular dysfunction; RETONCOMACE for cardio-oncology risk).
Two abstracts on AI-derived retinal biomarkers for cardiovascular risk accepted to ACC 2026 in New Orleans (OCTA biomarkers for coronary microvascular dysfunction; RETONCOMACE for cardio-oncology risk).